Skip to content

Clinical trials

Hypertension trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Phase: Not applicable Clear all

2,545 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20017
200216
200319
200431
200539
200651
200738
200862
200973
201071
201183
201286
201387
2014103
2015108
201692
2017108
2018129
2019145
2020115
2021133
2022178
2023195
2024181
2025192
2026170

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed1,518
Unknown status320
Recruiting256
Not yet recruiting142
Active, not recruiting115
Terminated93
Withdrawn61
Enrolling by invitation33
Suspended7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Johns Hopkins University36
Duke University32
NYU Langone Health31
University of Pennsylvania30
VA Office of Research and Development30
Brigham and Women's Hospital29
University of Alabama at Birmingham29
University of California, San Francisco26
University of Michigan22
Massachusetts General Hospital18

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension2,545
Diabetes Mellitus387
Obesity272
Cardiovascular Diseases255
Diabetes Mellitus, Type 2172
Dyslipidemias131
Hyperlipidemias110
Overweight93
Metabolic Syndrome91
Renal Insufficiency, Chronic91

Trials

Showing 76 to 100 of 2,545. Each trial links to its page on Pharma Observatory.

2,445 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.